Rana Saifi: An Exciting Time for the Bleeding Disorders Community
Rana Saifi, Regional Manager of Middle East at World Federation of Hemophilia, shared World Federation of Hemophilia’s post on LinkedIn, adding:
“Exciting time for the bleeding disorders community with this high level advocacy led by WHO Member States and supported actively by the WFH.”
Quoting World Federation of Hemophilia’s post:
“Today, the World Federation of Hemophilia joins global health leaders at the World Health Organization 158th Executive Board meeting in Geneva EB158, where a landmark Member State-led resolution on Global Action to Advance Health Equity for People with Hemophilia and Other Bleeding Disorders is on the agenda.
This resolution is led by Armenia with co-sponsorship by Bosnia & Herzegovina, Egypt, Georgia, Iraq, Latvia, Malta, Morocco, Nepal, Paraguay, Spain, Sri Lanka and Togo.
The draft resolution text can be viewed on the WHO EB158 website.
Follow us on our social media channels today, as we will share WHO EB158 live streaming web-link, as the discussion on this resolution is planned to take place later today Treatment For All.”
More posts featuring Rana Saifi.
-
Mar 19, 2026, 15:29Riten Kumar: Diagnosis and Management of Post-Thrombotic Sequelae Following Non-Extremity VTE in Children
-
Mar 19, 2026, 15:25Tom Rifai: Menopause as a Critical Window for Cardiometabolic Prevention
-
Mar 19, 2026, 15:16Glen Pyle: Association Between Premature Menopause and Coronary Heart Disease Risk
-
Mar 19, 2026, 15:14Georgiana Toma: Addressing Iron Deficiency Without Anemia
-
Mar 19, 2026, 15:01Erik Nelson: The Biomarker that Connects Heart, Brain, and DNA
-
Mar 18, 2026, 16:34Richard Buka: Exploring the COBRRA Trial in the Latest Episode of Don’t Just Read the Abstract
-
Mar 18, 2026, 16:22Heghine Khachatryan: Navigating the New Era of Hemophilia Gene Therapy
-
Mar 18, 2026, 16:21Georges Chahoud: Top Take-Home Messages from the AHA/ACC/Multisociety Acute PE Guideline
-
Mar 18, 2026, 16:19Cedric Hermans: Unleashing the Potential of Physical Activity in Hemophilia A Patients